Malvi Savani

534 total citations
18 papers, 227 citations indexed

About

Malvi Savani is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Malvi Savani has authored 18 papers receiving a total of 227 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 6 papers in Pathology and Forensic Medicine and 3 papers in Molecular Biology. Recurrent topics in Malvi Savani's work include Lymphoma Diagnosis and Treatment (5 papers), Viral-associated cancers and disorders (3 papers) and Vascular Tumors and Angiosarcomas (2 papers). Malvi Savani is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Viral-associated cancers and disorders (3 papers) and Vascular Tumors and Angiosarcomas (2 papers). Malvi Savani collaborates with scholars based in United States, France and Lebanon. Malvi Savani's co-authors include Mohamad Mohty, Julie E. Bauman, Ricklie Julian, Keith M. Skubitz, Bipin N. Savani, Éolia Brissot, Ali Bazarbachi, Rémy Duléry, Razan Mohty and Abdul Hamid Bazarbachi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and British Journal of Haematology.

In The Last Decade

Malvi Savani

17 papers receiving 226 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Malvi Savani United States 10 79 60 49 48 48 18 227
Praveen Ramakrishnan Geethakumari United States 9 183 2.3× 50 0.8× 79 1.6× 41 0.9× 49 1.0× 51 304
E. Seyrek Türkiye 10 79 1.0× 47 0.8× 72 1.5× 32 0.7× 24 0.5× 22 263
Ruemu Birhiray United States 8 80 1.0× 50 0.8× 80 1.6× 71 1.5× 51 1.1× 32 241
Melania Carlisi Italy 10 68 0.9× 74 1.2× 32 0.7× 105 2.2× 27 0.6× 38 268
Yuki Arakawa Japan 7 67 0.8× 31 0.5× 19 0.4× 37 0.8× 32 0.7× 31 201
Shiyuan Zhou China 9 51 0.6× 55 0.9× 11 0.2× 40 0.8× 37 0.8× 33 258
Silvia Trappolini Italy 7 48 0.6× 39 0.7× 79 1.6× 154 3.2× 96 2.0× 13 290
Wanda Knopińska‐Posłuszny Poland 9 93 1.2× 54 0.9× 84 1.7× 112 2.3× 29 0.6× 33 298
Ricardo López Almaraz Spain 11 43 0.5× 51 0.8× 31 0.6× 32 0.7× 17 0.4× 43 267
Marjan Ertault France 9 88 1.1× 43 0.7× 222 4.5× 63 1.3× 51 1.1× 14 306

Countries citing papers authored by Malvi Savani

Since Specialization
Citations

This map shows the geographic impact of Malvi Savani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malvi Savani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malvi Savani more than expected).

Fields of papers citing papers by Malvi Savani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Malvi Savani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malvi Savani. The network helps show where Malvi Savani may publish in the future.

Co-authorship network of co-authors of Malvi Savani

This figure shows the co-authorship network connecting the top 25 collaborators of Malvi Savani. A scholar is included among the top collaborators of Malvi Savani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Malvi Savani. Malvi Savani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Savani, Malvi & Rachna T. Shroff. (2022). Decision-Making Regarding Perioperative Therapy in Individuals with Localized Pancreatic Adenocarcinoma. Hematology/Oncology Clinics of North America. 36(5). 961–978. 1 indexed citations
3.
Pu, Jeffrey J., Malvi Savani, Nick Huang, & Elliot Epner. (2022). Mantle cell lymphoma management trends and novel agents: where are we going?. Therapeutic Advances in Hematology. 13. 1553998503–1553998503. 9 indexed citations
4.
Mohty, Razan, Rémy Duléry, Abdul Hamid Bazarbachi, et al.. (2021). Latest advances in the management of classical Hodgkin lymphoma: the era of novel therapies. Blood Cancer Journal. 11(7). 126–126. 27 indexed citations
5.
Savani, Malvi, et al.. (2021). Pegylated liposomal doxorubicin-induced renal toxicity in retroperitoneal liposarcoma: a case report and literature review. Cancer Chemotherapy and Pharmacology. 87(2). 289–294. 12 indexed citations
6.
Savani, Malvi, Olalekan O. Oluwole, & Bhagirathbhai Dholaria. (2021). New targets for CAR T therapy in hematologic malignancies. Best Practice & Research Clinical Haematology. 34(3). 101277–101277. 13 indexed citations
7.
Mohty, Razan, Malvi Savani, Éolia Brissot, & Mohamad Mohty. (2021). Nutritional Supplements and Complementary/Alternative Medications in Patients With Hematologic Diseases and Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 27(6). 467–473. 2 indexed citations
8.
Savani, Malvi, Rémy Duléry, Abdul Hamid Bazarbachi, et al.. (2021). Allogeneic haematopoietic cell transplantation for myelofibrosis: a real‐life perspective. British Journal of Haematology. 195(4). 495–506. 8 indexed citations
9.
Julian, Ricklie, Malvi Savani, & Julie E. Bauman. (2021). Immunotherapy Approaches in HPV-Associated Head and Neck Cancer. Cancers. 13(23). 5889–5889. 36 indexed citations
10.
Olszewski, Adam J., Izidore S. Lossos, Stephen D. Smith, et al.. (2020). Outcomes of Burkitt lymphoma (BL) managed in academic (Acad) or community (Comm) centers: real-world evidence (RWE) from 30 US sites.. Journal of Clinical Oncology. 38(15_suppl). 8043–8043.
11.
Savani, Malvi, Paari Murugan, & Keith M. Skubitz. (2019). Long-term cure of soft tissue sarcoma with pegylated-liposomal doxorubicin after doxorubicin and ifosfamide failure. SHILAP Revista de lepidopterología. 9(1). 1–1. 12 indexed citations
12.
Savani, Malvi, Mehmet Gençtürk, Ryan Shanley, et al.. (2019). Surveillance Imaging after Autologous Hematopoietic Cell Transplantation Predicts Survival in Patients with Diffuse Large B Cell Lymphoma. Biology of Blood and Marrow Transplantation. 26(2). 272–277. 3 indexed citations
13.
Savani, Malvi & Keith M. Skubitz. (2018). Long-term Outcome After Doxorubicin and Ifosfamide Overdose in a Patient With Osteosarcoma and BARD1 Mutation. Journal of Pediatric Hematology/Oncology. 41(2). e94–e96. 4 indexed citations
14.
Savani, Malvi, et al.. (2017). Characteristics and outcomes of very low birth weight infants receiving epinephrine during delivery room resuscitation. Resuscitation. 115. 1–4. 7 indexed citations
15.
Li, Zhuoyan, Samuel M. Rubinstein, Ramya Thota, et al.. (2016). Immune-Mediated Complications after Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 22(8). 1368–1375. 37 indexed citations
16.
Savani, Malvi, et al.. (2016). What do we need to know about allogeneic hematopoietic stem cell transplant survivors?. Bone Marrow Transplantation. 51(8). 1025–1031. 15 indexed citations
17.
Jain, Neha, Malvi Savani, Manyoo Agarwal, & Dipen Kadaria. (2016). Methimazole-induced insulin autoimmune syndrome. Therapeutic Advances in Endocrinology and Metabolism. 7(4). 178–181. 15 indexed citations
18.
Savani, Malvi, Yan Guo, David P. Carbone, & Ildiko Csiki. (2012). Sonic hedgehog pathway expression in non-small cell lung cancer. Therapeutic Advances in Medical Oncology. 4(5). 225–233. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026